These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6100612

  • 1. Physiological effects of short-term treatment with enalapril in hypertensive patients.
    de Leeuw PW, Hoogma RP, van Soest GA, van Es PN, Birkenhäger WH.
    J Hypertens Suppl; 1983 Oct; 1(1):87-91. PubMed ID: 6100612
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of enalapril on renin, angiotensin converting enzyme activity, aldosterone and prostaglandins in patients with hypertension.
    Larochelle P, Gutkowska J, Schiffrin E, Kuchel O, Hamet P, Genest J.
    Clin Invest Med; 1985 Oct; 8(3):197-201. PubMed ID: 2994932
    [Abstract] [Full Text] [Related]

  • 6. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA, Baker KM, Ayers CR, Weaver BA, Lehman MR.
    J Cardiovasc Pharmacol; 1985 Oct; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL, Henik RA, Stepien RL.
    Vet Ther; 2002 Oct; 3(2):157-66. PubMed ID: 19750747
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A.
    Blood Press Suppl; 1995 Oct; 1():1-45. PubMed ID: 7599749
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
    Valvo E, Gammaro L, Bedogna V, Tonon M, Giorgetti P, Pica B, Antonini P, Tessitore N, Oldrizzi L, Rugiu C.
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J, Brunner HR, Gavras I, Waeber B, Gavras H.
    J Cardiovasc Pharmacol; 1982 Dec; 4(6):966-72. PubMed ID: 6185790
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?
    Wu RA, Kailasam MT, Cervenka JH, Parmer RJ, Kennedy BP, Ziegler MG, O'Connor DT.
    J Hypertens; 1994 Nov; 12(11):1243-7. PubMed ID: 7868871
    [Abstract] [Full Text] [Related]

  • 20. Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.
    Kornerup HJ, Pedersen EB, Pedersen A, Pedersen G, Christensen NJ.
    Postgrad Med J; 1980 Nov; 56 Suppl 2():49-52. PubMed ID: 7001422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.